Relay Therapeutics (RLAY) Short Interest Ratio & Short Volume → He called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (From InvestorPlace) (Ad) Free RLAY Stock Alerts $6.64 +0.13 (+2.00%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Relay Therapeutics Short Interest DataCurrent Short Volume11,530,000 sharesPrevious Short Volume10,690,000 sharesChange Vs. Previous Month+7.86%Dollar Volume Sold Short$75.18 millionShort Interest Ratio / Days to Cover9.4Last Record DateApril 30, 2024Outstanding Shares132,740,000 sharesPercentage of Shares Shorted8.69%Today's Trading Volume1,508,418 sharesAverage Trading Volume1,209,191 sharesToday's Volume Vs. Average125% Short Selling Relay Therapeutics ? Sign up to receive the latest short interest report for Relay Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatRLAY Short Interest Over TimeRLAY Days to Cover Over TimeRLAY Percentage of Float Shorted Over Time Ad AltimetryUrgent Nvidia WarningCould Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.Click here to access… Relay Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202411,530,000 shares $75.18 million +7.9%N/A9.4 $6.52 4/15/202410,690,000 shares $73.01 million -4.3%N/A9 $6.83 3/31/202411,170,000 shares $92.71 million -5.4%N/A10 $8.30 3/15/202411,810,000 shares $93.89 million +7.4%N/A10.9 $7.95 2/29/202411,000,000 shares $110.22 million +12.1%N/A10.5 $10.02 2/15/20249,810,000 shares $104.67 million +3.8%N/A9.2 $10.67 Get the Latest News and Ratings for RLAY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Relay Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20249,450,000 shares $87.41 million -16.3%11.0%9.5 $9.25 1/15/202411,290,000 shares $124.19 million -6.0%13.1%10.3 $11.00 12/31/202312,010,000 shares $132.23 million -12.3%14.1%10.4 $11.01 12/15/202313,700,000 shares $138.92 million -6.4%16.1%11.5 $10.14 11/30/202314,630,000 shares $115.72 million -0.1%17.3%12.1 $7.91 11/15/202314,640,000 shares $125.17 million +1.5%17.3%12.7 $8.55 10/31/202314,430,000 shares $95.24 million +4.8%16.9%12.9 $6.60 10/15/202313,770,000 shares $106.58 million -29.0%16.3%13.5 $7.74 9/30/202319,400,000 shares $163.15 million -3.4%22.9%19.9 $8.41 9/15/202320,080,000 shares $188.15 million +1.0%23.7%21 $9.37 8/31/202319,890,000 shares $203.28 million -3.9%23.5%19.1 $10.22 8/15/202320,700,000 shares $219.83 million +5.5%24.5%18.3 $10.62 7/31/202319,630,000 shares $247.34 million -1.1%23.3%16.4 $12.60 7/15/202319,840,000 shares $242.64 million -3.1%23.8%14.7 $12.23 6/30/202320,480,000 shares $257.23 million -2.9%24.6%12.1 $12.56 6/15/202321,080,000 shares $269.61 million -0.4%25.3%12.3 $12.79 5/31/202321,160,000 shares $235.72 million -1.5%25.4%13.1 $11.14 5/15/202321,480,000 shares $221.03 million +8.5%25.8%13.6 $10.29 4/30/202319,800,000 shares $225.13 million +1.4%23.4%13 $11.37 4/15/202319,530,000 shares $340.60 million +3.3%23.1%13.3 $17.44 3/31/202318,910,000 shares $311.45 million +5.5%22.4%15.4 $16.47 3/15/202317,930,000 shares $295.85 million +0.8%21.3%13.8 $16.50 2/28/202317,780,000 shares $287.15 million +3.0%21.1%13 $16.15 2/15/202317,270,000 shares $317.25 million -0.6%20.6%12.9 $18.37 1/31/202317,380,000 shares $372.97 million -6.9%20.7%13 $21.46 1/15/202318,660,000 shares $387.57 million +10.5%22.2%14.7 $20.77 12/30/202216,890,000 shares $252.34 million +25.8%20.0%13.8 $14.94 12/15/202213,430,000 shares $230.59 million +7.5%15.9%12.2 $17.17 11/30/202212,490,000 shares $232.06 million -4.3%14.8%11.1 $18.58 11/15/202213,050,000 shares $258.39 million -3.1%15.4%10.5 $19.80 10/31/202213,460,000 shares $299.08 million +3.1%16.5%10.9 $22.22 10/15/202213,060,000 shares $254.80 million +7.2%16.1%10.4 $19.51 9/30/202212,180,000 shares $272.47 million +4.0%15.0%10.2 $22.37 9/15/202211,710,000 shares $293.69 million -25.0%15.9%9.2 $25.08How Biden has already won 2024 (Ad)Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that will forever enshrine Obama’s destructive, Marxist vision for America… A plot that could hand him and his allies near-total control over the government, your way of life, and your future.Click here to watch this now before it’s too late. RLAY Short Interest - Frequently Asked Questions What is Relay Therapeutics' current short interest? Short interest is the volume of Relay Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 11,530,000 shares of RLAY short. Learn More on Relay Therapeutics' current short interest. What is a good short interest ratio for Relay Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RLAY shares currently have a short interest ratio of 9.0. Learn More on Relay Therapeutics's short interest ratio. Is Relay Therapeutics' short interest increasing or decreasing? Relay Therapeutics saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 11,530,000 shares, an increase of 7.9% from the previous total of 10,690,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Relay Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Relay Therapeutics: Mesoblast Limited (0.79%), REGENXBIO Inc. (8.65%), CARGO Therapeutics, Inc. (13.99%), Humacyte, Inc. (4.99%), ProKidney Corp. (22.89%), Immatics (10.50%), HilleVax, Inc. (3.29%), Autolus Therapeutics plc (1.32%), Exscientia plc (3.71%), iTeos Therapeutics, Inc. (7.23%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Relay Therapeutics stock? Short selling RLAY is an investing strategy that aims to generate trading profit from Relay Therapeutics as its price is falling. RLAY shares are trading up $0.13 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Relay Therapeutics? A short squeeze for Relay Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RLAY, which in turn drives the price of the stock up even further. How often is Relay Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RLAY, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: MESO Short Squeeze RGNX Short Squeeze CRGX Short Squeeze HUMA Short Squeeze PROK Short Squeeze IMTX Short Squeeze HLVX Short Squeeze AUTL Short Squeeze EXAI Short Squeeze ITOS Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RLAY) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetryCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMost important medical advance in 100 yearsThe Oxford ClubNext President (Not Trump. Not Biden.)The Freeport SocietyCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceProtect Your Bank Account Before It’s Too LateWeiss Ratings